Autolus

Website: Autolus


Description: 

Autolus is at the forefront of a revolution in cancer treatment. Chimeric Antigen Receptor (CAR) T-cell therapies have been shown to be effective in some haematological malignancies and may have wide applications as a cancer treatment, with the potential to offer a cure.

Autolus is a leader in T-cell programming and manufacturing technology. Working in partnership with physicians and other healthcare providers, we extract immune cells from patients, equip them with a receptor that targets the cancer cell and infuse them back into the patient in order to combat cancer more effectively.

Location(s): 
London
United Kingdom